betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
betamethasone
RxCUI: 833461
What the CMS Formulary Data Shows for betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
Per the CMS 2026 Part D formulary file, betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion (RxNorm concept RXCUI 833461, generic name betamethasone) appears on 13 distinct formulary files spanning 180 Medicare Part D plan offerings - 3.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 5, with a cross-plan average of Tier 3.9.
Real-world access to betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion depends on utilization management as much as tier placement: 30.8% of covering formularies require prior authorization. 7.7% require step therapy. 23.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 407,711 Part D beneficiaries filled betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion in 2023, with total plan-and-beneficiary spending of $42,156,509 and an average per-beneficiary annual cost of $103.40. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion today.
Coverage Details
- Formularies covering
- 13
- Plans covering
- 180
- Coverage rate
- 3.6%
- Tier range
- Tier 3 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 30.8% of formularies
- Step therapy required
- 7.7% of formularies
- Quantity limits
- 23.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 407,711
- Total spending
- $42,156,509
- Avg per beneficiary
- $103.40
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion covered by Medicare Part D?
Yes, betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion is covered by 180 Medicare Part D plans (3.6% of all Part D formularies).
What tier is betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion on Medicare Part D plans?
betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion averages Tier 3.9 across Part D plans, ranging from Tier 3 to Tier 5.
Does betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion require prior authorization?
30.8% of Part D formularies require prior authorization for betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion. Step therapy: 7.7%. Quantity limits: 23.1%.
How much does Medicare spend on betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion?
In 2023, total Medicare Part D spending on betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion was $42,156,509, covering 407,711 beneficiaries. The average spend per beneficiary was $103.40.
Read our methodology - how this data is sourced, computed, and verified.